Dr Reddy's Laboratories Ltd 500124
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Shares in Generic-Drug Makers Fall After Trump's Tariff Plan — Update
Shares in Generic-Drug Makers Fall After Trump's Tariff Plan
Canada Approves Dr. Reddy's Generic Version of Novo Nordisk's Ozempic
Dr. Reddy's on Pace for Largest Percent Increase Since June 2025 — Data Talk
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs — 2nd Update
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs — Update
Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs
Trading Information
- Previous Close Price
- ₹1,385.00
- Day Range
- ₹1,372.50–1,398.00
- 52-Week Range
- ₹1,080.05–1,414.40
- Bid/Ask
- ₹0.00 / ₹0.00
- Shares Outstanding
- 833.66M
- Market Cap
- ₹1.15T
- Volume/Avg
- 55,416 / 99,802
Key Statistics
- Price/Earnings (Normalized)
- 41.72
- Price/Sales
- 3.48
- Dividend Yield (Trailing)
- 0.58%
- Dividend Yield (Forward)
- 0.58%
- Dividend Payment Schedule
- Jul
- Total Yield
- 0.58%
Company Profile
Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 27,527
- Website
- https://www.drreddys.com
Competitors
Valuation
Metric | 500124 | VTRS | TEVA |
|---|---|---|---|
Price/Earnings (Normalized) | 41.72 | 15.74 | 15.91 |
Price/Book Value | 2.98 | 1.76 | 6.32 |
Price/Sales | 3.48 | 1.65 | 2.96 |
Price/Cash Flow | 23.49 | 9.06 | 16.63 |
Price/Earnings
500124
VTRS
TEVA
Financial Strength
Metric | 500124 | VTRS | TEVA |
|---|---|---|---|
Quick Ratio | 1.32 | 0.82 | 0.51 |
Current Ratio | 1.93 | 1.55 | 0.95 |
Interest Coverage | 8.21 | −0.11 | 1.42 |
Quick Ratio
500124
VTRS
TEVA
Profitability
Metric | 500124 | VTRS | TEVA |
|---|---|---|---|
Return on Assets (Normalized) | 6.30% | 8.21% | 6.94% |
Return on Equity (Normalized) | 9.56% | 20.56% | 35.60% |
Return on Invested Capital (Normalized) | 8.27% | 11.60% | 13.90% |
Return on Assets
500124
VTRS
TEVA
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|^B>>!<j | LOCK|?&mT | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|&&^Kx^y | LOCK|M^^HJ | $50B | |||
| Haleon PLC ADR HLN | LOCK|%$jfq^ | LOCK|%$ | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|^gs&KMz | LOCK|R^b | $34B | |||
| Viatris Inc VTRS | LOCK|^Vs!^yL | LOCK|WZ | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|b>@ | LOCK|w$Y | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|yrGQ#l | LOCK|$l | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|<!<p^< | LOCK|LlH | $5B | |||
| Perrigo Co PLC PRGO | LOCK|fJ>C^&? | LOCK|?N | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|@Q!cJSv | LOCK|!<z&D | $2B |
United States